BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11590337)

  • 1. [Prevalence of hyperhidrosis in a population treated by beta-blocker].
    Figarella I; Tréchot P; Girard F; Barbaud A; Aliot E; Schmutz JL
    Ann Dermatol Venereol; 2001 Sep; 128(8-9):877-81. PubMed ID: 11590337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.
    Strutton DR; Kowalski JW; Glaser DA; Stang PE
    J Am Acad Dermatol; 2004 Aug; 51(2):241-8. PubMed ID: 15280843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical beta-blockers are not associated with an increased risk of treatment for depression.
    Kaiserman I; Kaiserman N; Elhayany A; Vinker S
    Ophthalmology; 2006 Jul; 113(7):1077-80. PubMed ID: 16815397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.
    Koelling TM; Joseph S; Aaronson KD
    J Heart Lung Transplant; 2004 Dec; 23(12):1414-22. PubMed ID: 15607672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.
    Lang DM; Alpern MB; Visintainer PF; Smith ST
    Arch Intern Med; 1993 Sep; 153(17):2033-40. PubMed ID: 8102844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.
    Tattersall C; Vernon S; Singh R
    Eye (Lond); 2006 Feb; 20(2):221-5. PubMed ID: 15803169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
    Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
    J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use is associated with improved outcomes in adult trauma patients.
    Arbabi S; Campion EM; Hemmila MR; Barker M; Dimo M; Ahrns KS; Niederbichler AD; Ipaktchi K; Wahl WL
    J Trauma; 2007 Jan; 62(1):56-61; discussion 61-2. PubMed ID: 17215733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility.
    Sugimura H; Spratt EH; Compeau CG; Kattail D; Shargall Y
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1370-6; discussion 1376-7. PubMed ID: 19464450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Video-assisted transthoracic sympathectomy in the treatment of primary hyperhidrosis: friend or foe?
    Fredman B; Zohar E; Shachor D; Bendahan J; Jedeikin R
    Surg Laparosc Endosc Percutan Tech; 2000 Aug; 10(4):226-9. PubMed ID: 10961751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical glycopyrrolate for patients with facial hyperhidrosis.
    Kim WO; Kil HK; Yoon KB; Yoon DM
    Br J Dermatol; 2008 May; 158(5):1094-7. PubMed ID: 18294315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis.
    Krogstad AL; Mork C; Piechnik SK
    Br J Dermatol; 2006 Jun; 154(6):1118-22. PubMed ID: 16704643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of compensatory sweating after thoracoscopic sympathectomy.
    Licht PB; Pilegaard HK
    Ann Thorac Surg; 2004 Aug; 78(2):427-31. PubMed ID: 15276490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does beta blocker therapy affect the diagnostic accuracy of adenosine single-photon-emission computed tomographic myocardial perfusion imaging?
    Lakkireddy D; Aronow WS; Bateman T; McGhee I; Nair C; Khan IA
    Am J Ther; 2008; 15(1):19-23. PubMed ID: 18223349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability to beta-blocker therapy among heart failure patients in clinical practice.
    Butler J; Khadim G; Belue R; Chomsky D; Dittus RS; Griffin M; Wilson JR
    J Card Fail; 2003 Jun; 9(3):203-9. PubMed ID: 12815570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needs analysis for the development of a preoperative clinic protocol for perioperative beta-blocker therapy.
    Hepner DL; Correll DJ; Beckman JA; Klickovich RJ; Park KH; Govindarajulu U; Bader AM
    J Clin Anesth; 2008 Dec; 20(8):580-8. PubMed ID: 19100930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.